Pharmavite, FDA Offer Alternate Takes On GMP Compliance Strategy
This article was originally published in The Tan Sheet
Executive Summary
A Pharmavite executive outlined a “different perspective” from the conventional wisdom promoted by FDA on successful compliance with dietary supplement good manufacturing practices: an emphasis on finished product specifications.
You may also be interested in...
GMP Qualification And Testing Provisions Still Trip Supplement Firms
A year after the final step in the three-year rollout of the dietary supplement good manufacturing practices final rule, firms large and small are learning the hard way what FDA expects to find in a facility.
FDA's Reynolds Marks Top GMP Trouble Spots As Deadline Looms
Some dietary supplement firms will not be ready to comply with good manufacturing practices by the rapidly approaching final deadline, according to a senior FDA advisor on supplement products
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.